Reklama
WIG82 745,58+1,45%
WIG202 436,05+1,72%
EUR / PLN4,29-0,29%
USD / PLN3,98-0,32%
CHF / PLN4,41-0,34%
GBP / PLN5,03-0,22%
EUR / USD1,08+0,02%
DAX18 492,49+0,08%
FT-SE7 952,60+0,26%
CAC 408 205,81+0,01%
DJI39 807,37+0,12%
S&P 5005 254,35+0,11%
ROPA BRENT87,07+1,60%
ROPA WTI82,70+1,20%
ZŁOTO2 234,24+0,06%
SREBRO25,03+1,87%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

wiadomosć espi SOPHARMA AD 2021-03-31 13:25

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No10/2021
Date of issue:2021-03-31
Short name of the issuer
SOPHARMA AD
Subject
Annual Audited Individual Financial Statements for 2020 of Sopharma AD
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Annual Audited Individual Financial Statements for 2020 of Sopharma AD
Annexes
FileDescription
SFA_Annual_Audited_Individual_Financial_Statements_ for_ 2020.rarAnnual Audited Individual Financial Statements for 2020 of Sopharma AD
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2021-03-31Ognian DonevExecutive Director
Czytaj więcej

Artykuły związane z wiadomosć espi SOPHARMA AD 2021-03-31 13:25